Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nitric oxide-dependent endothelial function and cardiovascular disease.

F Desjardins1, J L Balligand

  • 1Department of Medicine, Unit of Pharmacology and Therapeutics, Université Catholique de Louvain, Brussels, Belgium.

Acta Clinica Belgica
|February 28, 2007
PubMed
Summary

Nitric oxide, crucial for vascular health, becomes deficient in endothelial dysfunction, contributing to cardiovascular diseases. This review explores nitric oxide

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic deletion of aquaporin-1 results in microcardia and low blood pressure in mouse with intact nitric oxide-dependent relaxation, but enhanced prostanoids-dependent relaxation.

Pflugers Archiv : European journal of physiology·2013
Same author

Role of caveolar compartmentation in endothelium-derived hyperpolarizing factor-mediated relaxation: Ca2+ signals and gap junction function are regulated by caveolin in endothelial cells.

Circulation·2008
Same author

Rosuvastatin restores superoxide dismutase expression and inhibits accumulation of oxidized LDL in the aortic arch of obese dyslipidemic mice.

British journal of pharmacology·2007
Same author

Nitric oxide and the heart: update on new paradigms.

Annals of the New York Academy of Sciences·2005
Same author

Nitric oxide "at heart": emerging paradigms after a decade.

Archives des maladies du coeur et des vaisseaux·2005
Same author

Endothelial beta3-adrenoceptors mediate vasorelaxation of human coronary microarteries through nitric oxide and endothelium-dependent hyperpolarization.

Circulation·2004

Area of Science:

  • Cardiovascular Science
  • Endothelial Biology
  • Molecular Medicine

Background:

  • Nitric oxide (NO), primarily from endothelial nitric oxide synthase (eNOS), regulates vascular tone, inflammation, and smooth muscle cell behavior.
  • Reduced NO bioavailability characterizes endothelial dysfunction, a key factor in cardiovascular pathologies.
  • Endothelial dysfunction is implicated in heart failure, hypertension, diabetes, and atherosclerosis.

Purpose of the Study:

  • To review nitric oxide-dependent endothelial dysfunction in cardiovascular diseases.
  • To discuss clinical detection, pathogenic mechanisms, and therapeutic strategies related to NO bioavailability.

Main Methods:

  • Literature review focusing on nitric oxide synthase isoforms and endothelial function.
  • Analysis of evidence linking endothelial dysfunction to cardiovascular disease development.

Related Experiment Videos

  • Exploration of clinical relevance and therapeutic interventions.

    • Main Results:

    • Endothelial nitric oxide (NO) plays a vital role in maintaining vascular homeostasis.
    • Decreased NO bioavailability is a hallmark of endothelial dysfunction across various cardiovascular conditions.
    • Multiple factors contribute to reduced NO levels in pathological states.

    Conclusions:

    • Nitric oxide-dependent endothelial dysfunction is central to cardiovascular disease pathogenesis.
    • Understanding NO's role is critical for diagnosing and treating these conditions.
    • Targeting NO pathways offers potential therapeutic avenues for cardiovascular diseases.